Decisions may depend on thymoma and what type of auto-antibodies are present ...

A new study has found that myasthenia gravis does not affect the long-term prognosis of patients with thymoma. The study analyzed the clinical and pathological data of 509 patients who underwent ...

.BUFFALO, N.Y. — The first-ever randomized study of the removal of the thymus gland in treating myasthenia gravis was conducted in 2016. Led by Gil I. Wolfe, MD, SUNY Distinguished Professor and the ...

The first-ever randomized study of the removal of the thymus gland in treating myasthenia gravis was conducted in 2016. Led by Gil I. Wolfe, SUNY Distinguished Professor and the Irvin and Rosemary ...

The analysis represents an effort to use bioinformatics to find potential new therapeutic targets for myasthenia gravis (MG). A new genetic analysis of patients with thymoma-associated myasthenia ...

Generalized MG should be suspected when clinicians see fluctuating, fatigable weakness ...

In 2011, at age 25, Youssef Heddaya was diagnosed with thymoma, a typically slow-growing tumor that develops in the thymus, a small organ in the chest that is vital to the immune system. Located near ...

Only 6% to 12% of patients with MG are truly seronegative (i.e., have negative standard assays for AChR antibodies and MuSK antibodies). 8 These individuals may also be referred to as double negative, ...